EnClear Therapies

Our mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Learn how we are innovating neurosurgery for patient comfort and targeted treatment. ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. We uniquely provide both established clinical products as well as pre-clinical development services for controlled drug and device delivery. Learn more about ClearPoint’s industry-leading solutions and services for translational research and clinical trials involving gene/cell therapy and drug delivery to the CNS. Cosgrove explains how the ClearPoint System’s innovative design allows the neurosurgeon to intraoperatively confirm target location and minimize insertions.

Our team is driven to overcome the current challenges of treating people living with severe neurological disorders. We have deep experience in gene therapy research and development, cerebrospinal fluid (CSF) biofluid dynamics, bioengineering, and chemistry, manufacturing and controls (CMC). Alcyone is pioneering next-generation CNS precision gene-based therapeutics for complex neurological conditions. We integrate innovation in neuroscience, precision dosing and delivery, and manufacturing capabilities to deliver transformative therapies to patients. Alcyone was established in 2012 on the premise that better delivery technology is needed to effectively treat complex neurological disorders.

We are focused on creating a combined therapeutic strategy, targeting multiple pertinent mechanisms in these complex diseases.Our research team and advisory board members are multidisciplinary professionals who have many years of experience with drug development and clinical programs, as well as personal connections to neurodegenerative diseases. Our vision is to provide remedies for people with fatal diseases, changing the course of their disease, extending their lifespan and enhancing quality of life.. Our mission is to develop combined therapies for complex diseases, targeting multiple mechanisms in a synergistic manner, whilst utilizing regulatory pathways to bring these drugs to market within short timelines. NeuroSense was established to help alleviate the challenges of patients. For that reason, we are dedicated to raising awareness of the diseases and assisting nonprofit organizations in their fundraising efforts. We are focused on creating combined therapeutic strategies, targeting the multiple pertinent mechanisms in these complex diseases. Our goal is to create combined therapies targeting the multiple pathways affected by these conditions. NeuroSense Therapeutics is a clinical-stage biopharmaceutical company, focusing on the discovery and development of targeted innovative therapeutics for neurodegenerative diseases.

Our goal is to transform the lives of patients with improved therapeutic options. We are focused on designing innovative trials with clinical endpoints directly related to patient benefit, and we seek to recruit patients who will benefit from treatment with our product candidates. Our skills in clinical development define our core expertise in central nervous system disorders.

Patients and physicians around the globe are waiting for your potential life-changing therapy for neuroinflammatory, neurodegenerative, pain, or other CNS diseases. We understand that every step matters in reaching your milestones. That's why we focus on bringing insight and methods that increase value of each study and translatability of the preclinical data. Our team of neuroscientists are specialists in pain, neuroinflammation, and neurodegeneration with the expertise to develop complex predictive studies. Our team has 70 years combined experience to accurately execute methods that characterize disease and enhance therapeutic potential.

Our mission is to provide the highest-quality preclinical efficacy contract services for Central Nervous System (CNS), vascular and other diseases for our clients, including biotech and pharmaceutical companies, as well as academic investigators. We provide high-level technical proficiency, as well as expert assistance in the planning, analysis and interpretation of preclinical efficacy studies. We have extensive experience and expertise in preclinical modelling of CNS and vascular diseases, as well as a thorough understanding of all aspects of the drug development pathway. We possess special expertise in small animal surgery, drug delivery methods, and behavioral assessment methods.